Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, Ramirez A, Schlaich M, Stergiou GS, Tomaszewski M et al (2020) 2020 International Society of Hypertension global hypertension practice guidelines. J Hypertens 38:982–1004. https://doi.org/10.1097/HJH.0000000000002453

Article  CAS  PubMed  Google Scholar 

Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A et al (2018) 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J 39:3021–3104. https://doi.org/10.1093/eurheartj/ehy339

Article  PubMed  Google Scholar 

Stevens PE, Levin A, Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members (2013) Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med 158:825–830. https://doi.org/10.7326/0003-4819-158-11-201306040-00007

Article  PubMed  Google Scholar 

Feidakis A, Panagiotou MR, Tsoukakis E, Bacharaki D, Gounari P, Nikolopoulos P, Marathias KP, Lionaki S, Vlahakos D (2021) Impact of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on acute kidney injury in emergency medical admissions. J Clin Med 10:412. https://doi.org/10.3390/jcm10030412

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tomson C, Tomlinson LA (2019) Stopping RAS inhibitors to minimize AKI: more harm than good? Clin J Am Soc Nephrol 14:617–619. https://doi.org/10.2215/CJN.14021118

Article  PubMed  PubMed Central  Google Scholar 

Arora P, Rajagopalam S, Ranjan R, Kolli H, Singh M, Venuto R, Lohr J (2008) Preoperative use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers is associated with increased risk for acute kidney injury after cardiovascular surgery. Clin J Am Soc Nephrol 3:1266–1273. https://doi.org/10.2215/CJN.05271107

Article  PubMed  PubMed Central  Google Scholar 

Thakar CV, Kharat V, Blanck S, Leonard AC (2007) Acute kidney injury after gastric bypass surgery. Clin J Am Soc Nephrol 2:426–430. https://doi.org/10.2215/CJN.03961106

Article  PubMed  Google Scholar 

Coca SG, Garg AX, Swaminathan M, Garwood S, Hong K, Thiessen-Philbrook H, Passik C, Koyner JL, Parikh CR, Tribe-Aki Consortium (2013) Preoperative angiotensin-converting enzyme inhibitors and angiotensin receptor blocker use and acute kidney injury in patients undergoing cardiac surgery. Nephrol Dial Transplant 28:2787–2799. https://doi.org/10.1093/ndt/gft405

Article  CAS  PubMed  PubMed Central  Google Scholar 

STARSurg Collaborative (2018) Association between peri-operative angiotensin-converting enzyme inhibitors and angiotensin-2 receptor blockers and acute kidney injury in major elective non-cardiac surgery: a multicentre, prospective cohort study. Anaesthesia 73:1214–1222. https://doi.org/10.1111/anae.14349

Article  CAS  Google Scholar 

van Diepen S, Norris CM, Zheng Y, Nagendran J, Graham MM, Gaete Ortega D, Townsend DR, Ezekowitz JA, Bagshaw SM (2018) Comparison of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker management strategies before cardiac surgery: a pilot randomized controlled registry trial. J Am Heart Assoc 7:e009917. https://doi.org/10.1161/JAHA.118.009917

Article  PubMed  PubMed Central  Google Scholar 

Bonavia A, Javaherian M, Skojec AJ, Chinchilli VM, Mets B, Karamchandani K (2019) Angiotensin axis blockade, acute kidney injury, and perioperative morbidity in patients undergoing colorectal surgery: a retrospective cohort study. Medicine (Baltimore) 98:e16872. https://doi.org/10.1097/MD.0000000000016872

Article  CAS  PubMed  Google Scholar 

Lim MA, Bloom RD (2020) Medical therapies to reduce delayed graft function and improve long-term graft survival: are we making progress? Clin J Am Soc Nephrol 15:13–15. https://doi.org/10.2215/CJN.13961119

Article  PubMed  Google Scholar 

Mannon RB (2018) Delayed graft function: the AKI of kidney transplantation. Nephron 140:94–98. https://doi.org/10.1159/000491558

Article  PubMed  Google Scholar 

Hoorn EJ, Walsh SB, McCormick JA, Zietse R, Unwin RJ, Ellison DH (2012) Pathogenesis of calcineurin inhibitor-induced hypertension. J Nephrol 25:269–275. https://doi.org/10.5301/jn.5000174

Article  CAS  PubMed  PubMed Central  Google Scholar 

Heinze G, Mitterbauer C, Regele H, Kramar R, Winkelmayer WC, Curhan GC, Oberbauer R (2006) Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. J Am Soc Nephrol 17:889–899. https://doi.org/10.1681/ASN.2005090955

Article  CAS  PubMed  Google Scholar 

Hernandez D, Muriel A, Abraira V, Perez G, Porrini E, Marrero D, Zamora J, Gonzalez-Posada JM, Delgado P, Rufino M, Torres A (2012) Renin-angiotensin system blockade and kidney transplantation: a longitudinal cohort study. Nephrol Dial Transplant 27:417–422. https://doi.org/10.1093/ndt/gfr276

Article  CAS  PubMed  Google Scholar 

Formica RN Jr, Friedman AL, Lorber MI, Smith JD, Eisen T, Bia MJ (2006) A randomized trial comparing losartan with amlodipine as initial therapy for hypertension in the early post-transplant period. Nephrol Dial Transplant 21:1389–1394. https://doi.org/10.1093/ndt/gfk058

Article  CAS  PubMed  Google Scholar 

Stevens KK, Patel RK, Clancy M, Jardine AG (2010) Angiotensin blockade is associated with early graft dysfunction after live donor renal transplantation. Transplantation 89:707–709. https://doi.org/10.1097/TP.0b013e3181c892f2

Article  CAS  PubMed  Google Scholar 

Israili ZH (2000) Clinical pharmacokinetics of angiotensin II (AT1) receptor blockers in hypertension. J Hum Hypertens 14(Suppl 1):S73-86. https://doi.org/10.1038/sj.jhh.1000991

Article  CAS  PubMed  Google Scholar 

Von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. https://doi.org/10.1016/j.jclinepi.2007.11.008